These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12376512

  • 1. Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates.
    Groves FD, Perez-Perez G, Zhang L, You WC, Lipsitz SR, Gail MH, Fraumeni JF, Blaser MJ.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1091-4. PubMed ID: 12376512
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, Li JY, Zhao L, Liu WD, Zhang JS, Ma JL, Samloff IM, Correa P, Blaser MJ, Xu GW, Fraumeni JF.
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [Abstract] [Full Text] [Related]

  • 3. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]

  • 4. [Studies on infection of Helicobacter pylori and their subtypes cagA+ and hspA+ in population living in the areas with high and low incidence of gastric cancer].
    Zhang L, Ma J, Pan K.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Mar; 32(2):67-9. PubMed ID: 10322798
    [Abstract] [Full Text] [Related]

  • 5. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M, Starzyńska T.
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [Abstract] [Full Text] [Related]

  • 6. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
    Mohar A, Ley C, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J.
    Am J Gastroenterol; 2002 Oct; 97(10):2530-5. PubMed ID: 12385434
    [Abstract] [Full Text] [Related]

  • 7. The pattern of CagA and VacA proteins in Helicobacter pylori seropositive asymptomatic children in western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2005 Sep; 26(9):1372-7. PubMed ID: 16155650
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, Lopez G, Colin D, Muñoz N, Kato I.
    J Natl Cancer Inst; 2007 Sep 05; 99(17):1328-34. PubMed ID: 17728213
    [Abstract] [Full Text] [Related]

  • 9. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T, Ren Z, Dunkley M, Clancy R, Maaroos HI, Labotkin R, Kull K, Uibo R.
    APMIS; 2006 May 05; 114(5):372-80. PubMed ID: 16725014
    [Abstract] [Full Text] [Related]

  • 10. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.
    Immunol Invest; 2007 May 05; 36(4):371-86. PubMed ID: 17691020
    [Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
    Janulaityte-Günther D, Kupcinskas L, Pavilonis A, Valuckas K, Percival Andersen L, Wadström T.
    FEMS Immunol Med Microbiol; 2005 May 01; 44(2):191-5. PubMed ID: 15866215
    [Abstract] [Full Text] [Related]

  • 12. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
    Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune Ki, Kawabe T, Shiratori Y, Omata M.
    Cancer; 2000 Apr 01; 88(7):1530-5. PubMed ID: 10738209
    [Abstract] [Full Text] [Related]

  • 13. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug 01; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

  • 14. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].
    Ma JL, Zhang L, Pan KF, Liu WD, Feng GS, You WC.
    Zhonghua Yi Xue Za Zhi; 2005 Oct 19; 85(39):2758-61. PubMed ID: 16324316
    [Abstract] [Full Text] [Related]

  • 15. Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.
    Janulaityte-Günther D, Kupcinskas L, Pavilonis A, Valuckas K, Wadström T, Andersen LP.
    FEMS Immunol Med Microbiol; 2007 Jul 19; 50(2):220-5. PubMed ID: 17567283
    [Abstract] [Full Text] [Related]

  • 16. [Helicobacter pylori genotypes and their association with host's immune response].
    Garza-González E, Pérez-Pérez GI, Tijerina-Menchaca R, Maldonado-Garza HJ, Bosques-Padilla FJ.
    Rev Gastroenterol Mex; 2002 Jul 19; 67(3):155-60. PubMed ID: 12653051
    [Abstract] [Full Text] [Related]

  • 17. [Seroprevalence of Helicobacter pylori anti-CagA antibodies and its relationship with epidemiologic factors in Santa Fe].
    Jiménez F, Demaría JL, Ahumada C, Nagel A, Baroni MR, Giugni MC, Méndez E.
    Acta Gastroenterol Latinoam; 2004 Jul 19; 34(1):16-20. PubMed ID: 15328663
    [Abstract] [Full Text] [Related]

  • 18. Relationship between Helicobacter pylori CagA status and colorectal cancer.
    Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J.
    Am J Gastroenterol; 2001 Dec 19; 96(12):3406-10. PubMed ID: 11774957
    [Abstract] [Full Text] [Related]

  • 19. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O.
    Helicobacter; 2004 Jun 19; 9(3):271-7. PubMed ID: 15165264
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients.
    Rudi J, Engler S, Theilmann L, Otto G, Stremmel W.
    Am J Gastroenterol; 1997 Sep 19; 92(9):1492-5. PubMed ID: 9317070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.